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BACKGROUND: Researchers and quality improvement
advocates sometimes use review of chart-documented
pain care processes to assess the quality of pain
management. Studies have found that primary care
providers frequently fail to document pain assessment
and management.
OBJECTIVES: To assess documentation of pain care
processes in an academic primary care clinic and
evaluate the validity of this documentation as a mea-
sure of pain care delivered.
DESIGN: Prospective observational study.
PARTICIPANTS: 237 adult patients at a university-
affiliated internal medicine clinic who reported any pain
in the last week.
MEASURES: Immediately after a visit, we asked
patients to report the pain treatment they received.
Patients completed the Brief Pain Inventory (BPI) to
assess pain severity at baseline and 1 month later. We
extracted documentation of pain care processes from
the medical record and used kappa statistics to assess
agreement between documentation and patient report
of pain treatment. Using multivariable linear regres-
sion, we modeled whether documented or patient-
reported pain care predicted change in pain at 1 month.
RESULTS: Participants’ mean age was 53.7 years, 66%
were female, and 74% had chronic pain. Physicians
documented pain assessment for 83% of visits. Patients
reported receiving pain treatment more often (67%)
than was documented by physicians (54%). Agreement
between documentation and patient report was moder-
ate for receiving a new pain medication (k=0.50) and
slight for receiving pain management advice (k=0.13).
In multivariable models, documentation of new pain
treatment was not associated with change in pain (p=
0.134). In contrast, patient-reported receipt of new pain
treatment predicted pain improvement (p=0.005).
CONCLUSIONS: Chart documentation underestimated
pain care delivered, compared with patient report.
Documented pain care processes had no relationship
with pain outcomes at 1 month, but patient report of
receiving care predicted clinically significant improve-
ment. Chart review measures may not accurately
reflect the pain management patients receive in pri-
mary care.
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INTRODUCTION
Concern that pain is inadequately assessed and treated in
numerous settings has prompted the Joint Commission and
Department of Veterans Affairs (VA), among others, to launch
initiatives aimed at improving the quality of pain manage-
ment. Assessing the quality of pain management is chal-
lenging because pain has heterogeneous causes, outcomes
are variable, and evaluation and treatment selection depend
on many factors. As a result, researchers and quality
improvement advocates have used review of chart-documented
pain evaluation and treatment processes to define quality pain
care and evaluate the effects of quality improvement initiatives.1,2
Pain symptoms, both acute and chronic, are among the
most common presenting problems in primary care.3,4 Prior
research has found that primary care providers often fail to
document attention to pain, leading some to conclude that
pain is commonly ignored and undertreated in primary care.5
This conclusion is warranted if documentation of pain care
processes accurately reflects the pain care delivered, but
documentation-based pain quality measures have not yet been
validated.
Our objectives were to assess documentation of pain care
processes in an academic primary care clinic and to evaluate
the validity of this documentation as a measure of pain care
delivered. We tested two hypotheses: (1) that physicians
under-document the pain care they deliver and (2) that
patient report of pain care received is more strongly
associated with outcomes than is documentation of pain
care.
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This study is a secondary analysis of a prospective observa-
tional study of pain assessment in primary care. Study
procedures have been previously reported.6 We enrolled partic-
ipants from September 2005 to March 2006 at a single large
university-affiliated general internal medicine clinic. Inclusion
criteria were age ≥18 years and at least one previous visit to
the same clinic. We excluded those who were unable to
complete a face-to-face interview in English. For this analysis,
we also excluded participants who reported no pain at all in
the past week during the baseline interview.
A research assistant approached consecutive available
patients while they were waiting to see their physician and
invited them to enroll in a study of symptoms in primary care.
We used a two-step informed consent process to minimize both
disruption to clinic flow and bias in the study. Initially, the
research assistant informed potential participants by present-
ing a brief study fact sheet. Those who initially agreed to
participate were asked two general questions, one about the
main reason for the visit and the other about concerns they
would like to discuss with the doctor that day. Study partici-
pants then saw their physician as scheduled. They were asked
to return to a designated room in the clinic to be interviewed
immediately after completing their physician visit.
Written informed consent was completed after the visit and
before the baseline interview. Participants were not notified of
the specific pain focus of the study at any time; rather, the
study was described on the fact sheet and consent form as
being “about why people go to the doctor, about common
symptoms people have, and about how doctors treat those
symptoms.” The University of North Carolina Biomedical
Institutional Review Board approved the study protocol and
informed consent process, and all participants provided
written informed consent.
All baseline survey data were collected by face-to-face
interview. One month later, the research assistant called
participants for a follow-up telephone interview.
Patient Measures
Brief Pain Inventory (BPI). Participants completed the BPI, our
primary measure of pain severity, at baseline and 1 month.
The BPI has been validated in primary care and is
recommended as a core outcome measure for pain studies.7–9
It includes two scales, a four-item measure of pain intensity
(BPI severity) and a seven-item measure of pain-related
functional impairment (BPI interference). Each scale has an
overall range of 0–10, with higher scores representing worse
pain. We dichotomized BPI severity as moderate-severe (BPI
severity ≥4) or mild (BPI severity <4).
Patient report of pain care processes. Immediately after their
clinic visit, participants answered three yes/no questions
about what their doctor did for their pain that day. They
reported whether or not they received: (1) advice about how to
manage pain, (2) any new medication for pain, and (3) any
new treatment other than medication for pain. We defined
“any new pain treatment” as receiving any of the three types
of pain care.
Patient Health Questionnaire (PHQ). We used the PHQ-8 to
assess depression at baseline. This measure excludes the item
on suicidal thoughts from the original PHQ-9, but has similar
test characteristics for detecting depression.10–12 A score ≥10
has a sensitivity of 80% and a specificity of 92% for major
depressive disorder.13 We classified patients as having anxiety
if they had panic disorder or other anxiety disorder according
to PHQ scoring criteria. The overall accuracy of PHQ anxiety
modules is 91%, compared with diagnosis of any DSM-III-R
anxiety disorder by a mental health professional.14
Other variables. During the baseline interview, we asked
participants to report their race/ethnicity, whether they saw
their “regular doctor” at the current visit, and the location
and duration of pain. We allowed them to report up to five
separate pain locations; for this analysis, we dichotomized
the number of pain locations as one vs. two or more sites. We
categorized the duration of pain as chronic if it was present
for ≥6 months.
Chart Review Measures
All chart-based measures came from the electronic medical
record (EMR). Physicians dictate clinical notes and enter
orders directly into the EMR. Two coders abstracted data from
physician notes and orders for the index clinic visit, as well as
from administrative and pharmacy records. A third coder
reviewed abstracted data for accuracy.
Pain care process variables. We abstracted the following pain
care processes: (1) pain assessment (any mention of location or
duration of pain), (2) order of any diagnostic test, (3) provision
of advice/education about management of pain symptoms, (4)
prescription of a new pain medication, (5) change in dose or
schedule of existing pain medication, and (6) new non-
pharmacologic pain treatment (e.g., specialty or therapist
referral for pain management, office procedure, order for
prosthetics). We also abstracted documented plans to
continue current pain therapy without change. In addition to
individual pain care processes, we created a composite
variable, “any new pain treatment,” if documentation of
advice, new pain medication, or new non-pharmacologic pain
treatment was present.
Other variables. We abstracted insurance information from the
administrative fields and categorized patients as privately
insured (any commercial health insurance), publicly insured
(Medicare or Medicaid only), or uninsured (no health insurance
listed). We abstracted age, sex, current medications, physician
type (resident or attending), medical comorbidities, and pain
specialty visits. Participants were counted as using opioids for
pain if they had a prescription for any Schedule 2 or 3 opioid
analgesic on their current medication list; we did not include
tramadol or cough preparations as opioids. We considered
patients to have concurrent pain clinic attendance if we found
evidence of an encounter in any of three pain specialty clinics
(anesthesia pain clinic, spine clinic, or internal medicine pain
clinic) within the prior year. Medical comorbidities, abstracted
from the problem list, included the following ten common
chronic conditions: arthritis, asthma/chronic lung disease,
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cancer, coronary artery disease, diabetes, heart failure,
hypertension, liver disease, kidney disease, and stroke.15
Analysis
We used descriptive statistics to report baseline characteristics
and rates of documented pain care processes. Using chi-
square tests, we compared rates for participants with moder-
ate-severe pain to those for participants with mild pain.
We calculated kappa statistics to assess agreement between
documentation and patient report for three pain care process-
es: (1) provision of advice/education about management of
pain symptoms, (2) prescription of a new medication, and (3)
new non-pharmacologic treatment. We also compared agree-
ment between documentation and patient report on the any
new pain treatment composite variable (positive if any of the
three individual pain care processes was present).
We used analysis of covariance to separately model whether
receipt of any new pain treatment according to physician
documentation or patient report predicted subsequent im-
provement in pain severity at 1-month follow-up. Secondarily,
we fit separate models for each of the three individual pain care
processes (i.e., advice, new medication, and new non-pharma-
cologic treatment). In all models, change in BPI severity score
between the visit and follow-up interview was the dependent
variable. We adjusted models for demographic variables and
potential confounders at baseline: age, sex, race (white/
nonwhite), health insurance status (public/private/none),
depression (yes/no), anxiety (yes/no), chronic pain (yes/no),
number of pain sites (1/ ≥2), and opioid use (yes/no). For all
models, we report the mean change and 95% confidence
intervals (CI).
We imputed missing data from BPI and PHQ scales using
best subset regression if one value was missing; we did not
impute data if more than one value was missing from a scale.
Our statistical package was Stata version 10.1 (Stata Corp.,
College Station, TX).
RESULTS
Of 548 patients who were invited to participate, 357 initially
agreed, 187 refused, and 4 were excluded for being unable to
complete the interview in English; 277 patients completed
baseline interviews. Those who initially agreed to participate
but did not complete the interview cited reasons such as lack
of time or need to go to the laboratory or radiology department
after their visit.6 We restricted this analysis to the 237
participants who reported experiencing any pain in the week
before the baseline interview. Of these, 199 (84%) were reached
for follow-up. The 38 participants who were lost to follow-up
were similar to those who completed it, but fewer had more
than one pain site (60% vs. 76%, p=0.04).
Patient Characteristics
Participants’ mean age was 53.7 years, and 66% were female
(Table 1). Participants saw 81 different physicians; 73%
reported they saw their “regular doctor” at the index visit.
The mean baseline BPI severity score was 5.2, consistent with
moderate pain intensity. At baseline, 79% had moderate or
severe pain. Nearly three-quarters of participants had chronic
pain (at least one pain symptom present for ≥6 months), and
74% reported pain in more than one location. Nearly one-third
of participants were receiving an opioid analgesic at baseline.
Medical and psychiatric comorbidities were common. Overall,
48% had either depression or anxiety; among those with
chronic pain, depression or anxiety was present in 56%.
Documentation of Pain Care Processes
Table 2 shows the frequency of specific pain care processes
documented in the chart. Overall, physicians documented
pain assessment for 197 (83%) of the visits. Documentation
of any new pain treatment was present for 54%. For nearly
one-quarter of visits, physicians documented a plan to contin-
ue current pain therapy. Patients with moderate-severe pain
were significantly more likely to have documented pain
assessment (88% vs. 64%, p<0.001) and any new pain
Table 1. Baseline Characteristics of Participants (n=237)
Characteristic Mean (SD) or %













Number of medical comorbiditiesa 2.0 (1.5)
Chronic pain 74.2
Pain chief complaint 40.1
BPI severity, mean (SD) 5.4 (2.3)
More than one pain site 73.8
Opioid use 31.2
Pain clinic attendance 14.8
aFrom a list of ten common chronic conditions (arthritis, asthma/chronic
lung disease, cancer, coronary artery disease, diabetes, heart failure,
hypertension, liver disease, kidney disease, and stroke)
Table 2. Documentation of Pain Care Processes Overall and by
Pain Severity at Baseline









Pain assessment 197 (83) 165 (88) 32 (64) <0.001
Diagnostic test 49 (21) 43 (23) 6 (12) 0.088
Advice 34 (14) 29 (16) 5 (10) 0.974
New medication 75 (32) 65 (35) 10 (20) 0.046
Change in existing
medication
27 (11) 25 (13) 2 (4) 0.064
New non-pharmacologic
treatment
52 (22) 48 (26) 4 (8) 0.007
Plan to continue
current therapy
56 (24) 46 (25) 10 (20) 0.497
Any new treatment
composite
129 (54) 112 (60) 17 (34) 0.001
*Chi-square test for difference between participants with moderate-
severe pain (BPI severity ≥4) and those with mild pain (BPI severity <4)
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treatment (60% vs. 34%, p=0.001) compared with those who
had mild pain.
Overall, patients reported receiving more pain care than was
documented (Table 3). This was true for each of the three
processes evaluated and for the composite new treatment
measure. Agreement between documentation and patient
report was best for new pain medication (k=0.50) and worst
for pain management advice (k=0.13).
Relationship of Pain Care Processes with Pain
Outcomes
Among 199 patients with follow-up data, the mean change in
BPI severity was -1.3 (SD 2.8) on a 0–10 scale (negative change
indicates improvement in pain). Overall, 58% of patients
reported improvement in pain intensity: 49% among those
with and 81% among those without chronic pain.
In multivariable models, receipt of any new pain treatment
according to chart documentation was not significantly associ-
ated with subsequent improvement in pain severity compared
with no documentation of new pain treatment (difference
between groups=0.6, p=0.134). In contrast, patients who
reported receiving any new pain treatment improved signifi-
cantly more than those who reported not receiving any new
treatment (difference between groups=1.2, p=0.005). A similar
pattern emerged when we fit separate models for each of the
three individual pain care processes: patient-reported receipt of
pain management advice and patient-reported receipt of new
medication predicted subsequent pain improvement. However,
none of the documented processes were significantly associat-
ed with subsequent change in pain severity. Table 4 shows
adjusted BPI severity score changes for those who did and
those who did not receive each of the pain care processes,
according to both documentation and patient report. In
general, for pain intensity scales scored from 0–10, a change
of ≥1 point or 10–20% is considered to be clinically significant,
and a change of ≥2 points or 30% is considered to be at least
moderately important.16
DISCUSSION
Using patient report as the reference, we found that documenta-
tion of pain care processes in the medical record underestimated
pain management delivered by physicians. Notably, patient-
reported receipt of pain management predicted clinically signif-
icant improvement, whereas chart-documented pain care was
not associated with patient outcomes. This pattern was observed
for both a compositemeasure and individual pain care processes.
These findings support our hypotheses and suggest that patient
report may more accurately reflect the quality of pain care than
does chart documentation.
Our study illustrates the medical complexity and competing
demands that form the context of pain management in many
primary care settings. Chronic disease comorbidity was com-
mon; 64% of participants had two or more chronic medical
conditions and 48% had concurrent depression or anxiety.
Most patients had primary concerns that were not pain-
related. Because the majority of pain problems in this study
were chronic in nature, we presume many of them had been
addressed in previous visits. Given these factors, we are
unsure what optimal pain assessment and management
documentation rates would be, but something less than
100% would likely be appropriate.
Despite the sample’s clinical complexity and pain chronicity,
we found relatively high rates of EMR-documented pain
assessment and management. Rates of documented pain
assessment (83%) and composite treatment (54%) in our study
are nearly twice as high as those reported by Mularski et al. in
their prior study based in VA primary care (49% and 28%,
respectively).2 Whether this reflects a difference in actual
practice or a difference in documentation between the two
clinics is unclear. Differences in documentation could be
Table 3. Agreement Between Documented and Patient-Reported
Pain Care Processes








129 (54) 159 (67) 0.34 <0.001
Advice 34 (14) 116 (49) 0.13 0.003
New medication 75 (32) 81 (34) 0.50 <0.001
New non-pharmacologic
treatment
52 (22) 75 (32) 0.35 <0.001
Table 4. Adjusted Change in BPI Severity According to Documented or Patient-Reported Receipt of Pain Care Processes (n=199)





Any new treatment composite -1.6 (-2.1, -1.1) -1.0 (-1.6, -0.4) 0.6 (-1.4, 0.2) 0.134
Advice -1.8 (-2.8, -0.8) -1.3 (-1.7, -0.8) 0.6 (-1.6, 0.5) 0.307
New medication -1.6 (-2.3, -0.9) -1.2 (-1.7, -0.8) 0.3 (-1.2, 0.5) 0.428
New non-pharmacologic treatment -1.1 (-2.0, -0.3) -1.4 (-1.8, -1.0) 0.3 (-0.7, 1.2) 0.596
Patient-reported processes
Any new treatment composite -1.7 (-2.2, -1.3) -0.5 (-1.2, 0.1) 1.2 (-2.0, -0.4) 0.005
Advice -1.8 (-2.3, -1.2) -0.9 (-1.4, -0.4) 0.9 (-1.6, -0.1) 0.024
New medication -2.2 (-2.8, -1.6) -0.9 (-1.3, -0.4) 1.3 (-2.1, -0.5) 0.001
New non- pharmacologic treatment -1.8 (-2.5, -1.2) -1.1 (-1.6, -0.7) 0.7 (-1.5, 0.1) 0.105
aScores on 0–10 scale, where higher scores indicate worse pain; negative change scores represent improvement
*P-values are for differences between patients who received and those who did not receive a given pain care process, adjusted for the following baseline
variables: age, sex, race, health insurance status, depression, anxiety, chronic pain, number of pain sites, and opioid use
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explained by the fact that physicians in our study dictated
notes, whereas those in the VA study typed directly into the
EMR. Typing is a more time-demanding mode of entry than
dictating, and may have affected the quality and quantity of
documentation.17
We conducted this study in a practice that lacked clinical
reminder tools to prompt physician documentation of pain
management. Many VA and non-VA clinics have implemented
clinical reminders to facilitate greater documentation of pain
management, but studies have not yet proven these tools to be
effective in improving care. A study by Saigh et al. illustrated
some potential pitfalls.18 They found that implementation of a
mandatory pain assessment module in their EMR did not
increase overall documentation of pain assessment, but did
increase contradictory documentation (“no pain” documented
in the mandatory pain assessment field despite free-text
documentation of pain evaluation). Providers in that study
reported the pain assessment tool was cumbersome and did
not alter their pain assessment practice.
We used patient report of pain management received as the
reference standard in this study. Although we recognize that
patient report may not perfectly reflect physicians’ words or
actions during the encounter, patient perceptions are clearly
relevant to symptom management. Previous studies have
found that patient perceptions of a visit more strongly predict
outcomes than observation-based or physician-reported mea-
sures.19,20 One possible explanation is that messages delivered
by a physician are sometimes not “received” or understood by
the patient. Additionally, patient perceptions may reflect
intangible therapeutic factors that affect outcomes, such as a
caring bedside manner.21
Our study has several limitations. First, we simply asked
patients whether or not they had received three types of pain
care (i.e., advice, medication, and non-pharmacologic treat-
ment) during the visit. We were primarily interested in
treatment and did not ask about other aspects of the visit,
such as pain assessment (e.g., history and physical exam).
Given the expected preponderance of chronic pain, we
thought ongoing attention to management of the pain would
likely be more important than assessment in terms of patient
outcomes. Second, we did not assess patient perceptions of
the value of the care they received. This would require in-
depth interviews that were beyond the scope of our study.
Third, this study was conducted in a single university-
affiliated clinic with an EMR, and results may not generalize
to other settings.
Given our findings, we believe that chart review-based pain
process measures should be used with caution until evidence
of their relationship with pain care quality and patient out-
comes is established. A potential hazard for quality improve-
ment programs that rely on chart review measures is that they
could promote increased documentation without changing the
quality of the actual care delivered. In our study, 49% of
patients reported receiving advice from their physician about
managing pain, but only 14% of physicians documented giving
such advice. If all physicians who gave advice started doc-
umenting it, an apparent 350% increase in physician advice
would be detected without any change in patient care. An
intervention that leads providers to spend more time on
documentation could even reduce face time with patients,
adversely affecting care.22 Using administrative data to evalu-
ate use of specific evidence-based practices for common pain
conditions may be a better approach than using chart-
documented pain assessment and management processes.
In summary, we found that documentation of pain care
processes underestimated pain management, when compared
with patient report. Documentation measures had no relation-
ship with pain outcomes at 1 month, whereas patient report of
care received predicted subsequent pain improvement. We
conclude that chart review-based pain care process measures
may insufficiently reflect the quality and effectiveness of pain
management in primary care.
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